Global Conjugate Vaccines Sales Market Report 2021

August 2016 | 106 pages | ID: G4B3065F6F6EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Conjugate Vaccines

Revenue, means the sales value of Conjugate Vaccines

This report studies sales (consumption) of Conjugate Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Astellas Pharma Inc
• CSL Limited
• Emergent BioSolutions, Inc
• GlaxoSmithKline
• Johnson & Johnson
• MedImmune, LLC
• Merck & Co
• Pfizer
• Sanofi Pasteur
• Serum Institute
• India Pvt. Ltd. (India)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Conjugate Vaccines in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Pneumococcal
• Influenza
• HPV
• Hepatitis
• Rotavirus
• DTP
• Polio
• MMR

Split by applications, this report focuses on sales, market share and growth rate of Conjugate Vaccines in each application, can be divided into

• Pediatric
• Adult
• Application 3

Contents

Global Conjugate Vaccines Sales Market Report 2021

1 CONJUGATE VACCINES OVERVIEW

1.1 Product Overview and Scope of Conjugate Vaccines
1.2 Classification of Conjugate Vaccines
  1.2.1 Pneumococcal
  1.2.2 Influenza
  1.2.3 HPV
  1.2.4 Hepatitis
  1.2.5 Rotavirus
  1.2.6 DTP
  1.2.7 Polio
  1.2.8 MMR
1.3 Applications of Conjugate Vaccines
  1.3.1 Pediatric
  1.3.2 Adult
  1.3.3 Application
1.4 Conjugate Vaccines Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Conjugate Vaccines (2011-2021)
  1.5.1 Global Conjugate Vaccines Sales, Revenue and Price (2011-2021)
  1.5.2 Global Conjugate Vaccines Sales and Growth Rate (2011-2021)
  1.5.3 Global Conjugate Vaccines Revenue and Growth Rate (2011-2021)

2 GLOBAL CONJUGATE VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Conjugate Vaccines Market Competition by Manufacturers
  2.1.1 Global Conjugate Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Conjugate Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Conjugate Vaccines (Volume and Value) by Type
  2.2.1 Global Conjugate Vaccines Sales and Market Share by Type (2011-2021)
  2.2.2 Global Conjugate Vaccines Revenue and Market Share by Type (2011-2021)
2.3 Global Conjugate Vaccines (Volume and Value) by Regions
  2.3.1 Global Conjugate Vaccines Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Conjugate Vaccines Revenue and Market Share by Regions (2011-2021)
2.4 Global Conjugate Vaccines (Volume) by Application

3 NORTH AMERICA CONJUGATE VACCINES (VOLUME, VALUE AND SALES PRICE

3.1 North America Conjugate Vaccines Sales and Value (2011-2021)
  3.1.1 North America Conjugate Vaccines Sales and Growth Rate (2011-2021)
  3.1.2 North America Conjugate Vaccines Revenue and Growth Rate (2011-2021)
  3.1.3 North America Conjugate Vaccines Sales Price Trend (2011-2021)
3.2 North America Conjugate Vaccines Sales and Market Share by Manufacturers
3.3 North America Conjugate Vaccines Sales and Market Share by Type
3.4 North America Conjugate Vaccines Sales and Market Share by Applications

4 CHINA CONJUGATE VACCINES (VOLUME, VALUE AND SALES PRICE

4.1 China Conjugate Vaccines Sales and Value (2011-2021)
  4.1.1 China Conjugate Vaccines Sales and Growth Rate (2011-2021)
  4.1.2 China Conjugate Vaccines Revenue and Growth Rate (2011-2021)
  4.1.3 China Conjugate Vaccines Sales Price Trend (2011-2021)
4.2 China Conjugate Vaccines Sales and Market Share by Manufacturers
4.3 China Conjugate Vaccines Sales and Market Share by Type
4.4 China Conjugate Vaccines Sales and Market Share by Applications

5 EUROPE CONJUGATE VACCINES (VOLUME, VALUE AND SALES PRICE

5.1 Europe Conjugate Vaccines Sales and Value (2011-2021)
  5.1.1 Europe Conjugate Vaccines Sales and Growth Rate (2011-2021)
  5.1.2 Europe Conjugate Vaccines Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Conjugate Vaccines Sales Price Trend (2011-2021)
5.2 Europe Conjugate Vaccines Sales and Market Share by Manufacturers
5.3 Europe Conjugate Vaccines Sales and Market Share by Type
5.4 Europe Conjugate Vaccines Sales and Market Share by Applications

6 JAPAN CONJUGATE VACCINES (VOLUME, VALUE AND SALES PRICE

6.1 Japan Conjugate Vaccines Sales and Value (2011-2021)
  6.1.1 Japan Conjugate Vaccines Sales and Growth Rate (2011-2021)
  6.1.2 Japan Conjugate Vaccines Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Conjugate Vaccines Sales Price Trend (2011-2021)
6.2 Japan Conjugate Vaccines Sales and Market Share by Manufacturers
6.3 Japan Conjugate Vaccines Sales and Market Share by Type
6.4 Japan Conjugate Vaccines Sales and Market Share by Applications

7 SOUTHEAST ASIA CONJUGATE VACCINES (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Conjugate Vaccines Sales and Value (2011-2021)
  7.1.1 Southeast Asia Conjugate Vaccines Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Conjugate Vaccines Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Conjugate Vaccines Sales Price Trend (2011-2021)
7.2 Southeast Asia Conjugate Vaccines Sales and Market Share by Manufacturers
7.3 Southeast Asia Conjugate Vaccines Sales and Market Share by Type
7.4 Southeast Asia Conjugate Vaccines Sales and Market Share by Applications

8 INDIA CONJUGATE VACCINES (VOLUME, VALUE AND SALES PRICE

8.1 India Conjugate Vaccines Sales and Value (2011-2021)
  8.1.1 India Conjugate Vaccines Sales and Growth Rate (2011-2021)
  8.1.2 India Conjugate Vaccines Revenue and Growth Rate (2011-2021)
  8.1.3 India Conjugate Vaccines Sales Price Trend (2011-2021)
8.2 India Conjugate Vaccines Sales and Market Share by Manufacturers
8.3 India Conjugate Vaccines Sales and Market Share by Type
8.4 India Conjugate Vaccines Sales and Market Share by Applications

9 GLOBAL CONJUGATE VACCINES MANUFACTURERS ANALYSIS

9.1 Astellas Pharma Inc
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Conjugate Vaccines Product Type and Technology
    9.1.2.1 Pneumococcal
    9.1.2.2 Influenza
  9.1.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.2 CSL Limited
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Conjugate Vaccines Product Type and Technology
    9.2.2.1 Pneumococcal
    9.2.2.2 Influenza
  9.2.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Emergent BioSolutions, Inc
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Conjugate Vaccines Product Type and Technology
    9.3.2.1 Pneumococcal
    9.3.2.2 Influenza
  9.3.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Conjugate Vaccines Product Type and Technology
    9.4.2.1 Pneumococcal
    9.4.2.2 Influenza
  9.4.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Johnson & Johnson
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Conjugate Vaccines Product Type and Technology
    9.5.2.1 Pneumococcal
    9.5.2.2 Influenza
  9.5.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.6 MedImmune, LLC
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Conjugate Vaccines Product Type and Technology
    9.6.2.1 Pneumococcal
    9.6.2.2 Influenza
  9.6.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.7 Merck & Co
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Conjugate Vaccines Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Pfizer
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Conjugate Vaccines Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Sanofi Pasteur
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Conjugate Vaccines Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Serum Institute
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Conjugate Vaccines Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Conjugate Vaccines Sales, Revenue, Price of Company One (2015 and 2021)
9.11 India Pvt. Ltd. (India)

10 CONJUGATE VACCINES TECHNOLOGY AND DEVELOPMENT TREND

10.1 Conjugate Vaccines Technology Analysis
10.2 Conjugate Vaccines Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Conjugate Vaccines
Table Classification of Conjugate Vaccines
Figure Global Sales Market Share of Conjugate Vaccines by Type in 2015
Figure Pneumococcal Picture
Figure Influenza Picture
Figure HPV Picture
Figure Hepatitis Picture
Figure Rotavirus Picture
Figure DTP Picture
Figure Polio Picture
Figure MMR Picture
Table Applications of Conjugate Vaccines
Figure Global Sales Market Share of Conjugate Vaccines by Applications in 2015
Figure Pediatric Examples
Figure Adult Examples
Figure North America Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure China Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure India Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Table Global Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure Global Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure Global Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Table Global Conjugate Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Global Conjugate Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Conjugate Vaccines Sales Share by Manufacturers
Figure 2016 Conjugate Vaccines Sales Share by Manufacturers
Table Global Conjugate Vaccines Revenue by Manufacturers (2015 and 2016)
Table Global Conjugate Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Conjugate Vaccines Revenue Share by Manufacturers
Table 2016 Global Conjugate Vaccines Revenue Share by Manufacturers
Table Global Conjugate Vaccines Sales and Market Share by Type (2011-2021)
Table Global Conjugate Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Conjugate Vaccines by Type (2011-2021)
Figure Global Conjugate Vaccines Sales Growth Rate by Type (2011-2021)
Table Global Conjugate Vaccines Revenue and Market Share by Type (2011-2021)
Table Global Conjugate Vaccines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Conjugate Vaccines by Type (2011-2021)
Figure Global Conjugate Vaccines Revenue Growth Rate by Type (2011-2021)
Table Global Conjugate Vaccines Sales and Market Share by Regions (2011-2021)
Table Global Conjugate Vaccines Sales Share by Regions (2011-2021)
Figure Sales Market Share of Conjugate Vaccines by Regions (2011-2021)
Figure Global Conjugate Vaccines Sales Growth Rate by Regions (2011-2021)
Table Global Conjugate Vaccines Revenue and Market Share by Regions (2011-2021)
Table Global Conjugate Vaccines Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Conjugate Vaccines by Regions (2011-2021)
Figure Global Conjugate Vaccines Revenue Growth Rate by Regions (2011-2021)
Table Global Conjugate Vaccines Sales and Market Share by Application (2011-2021)
Table Global Conjugate Vaccines Sales Share by Application (2011-2021)
Figure Sales Market Share of Conjugate Vaccines by Application (2011-2021)
Figure Global Conjugate Vaccines Sales Growth Rate by Application (2011-2021)
Figure North America Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure North America Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure North America Conjugate Vaccines Sales Price Trend (2011-2021)
Table North America Conjugate Vaccines Sales by Manufacturers (2015 and 2016)
Table North America Conjugate Vaccines Market Share by Manufacturers (2015 and 2016)
Table North America Conjugate Vaccines Sales by Type (2015 and 2016)
Table North America Conjugate Vaccines Market Share by Type (2015 and 2016)
Table North America Conjugate Vaccines Sales by Applications (2015 and 2016)
Table North America Conjugate Vaccines Market Share by Applications (2015 and 2016)
Figure Europe Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Conjugate Vaccines Sales Price Trend (2011-2021)
Table Europe Conjugate Vaccines Sales by Manufacturers (2015 and 2016)
Table Europe Conjugate Vaccines Market Share by Manufacturers (2015 and 2016)
Table Europe Conjugate Vaccines Sales by Type (2015 and 2016)
Table Europe Conjugate Vaccines Market Share by Type (2015 and 2016)
Table Europe Conjugate Vaccines Sales by Applications (2015 and 2016)
Table Europe Conjugate Vaccines Market Share by Applications (2015 and 2016)
Figure China Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure China Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure China Conjugate Vaccines Sales Price Trend (2011-2021)
Table China Conjugate Vaccines Sales by Manufacturers (2015 and 2016)
Table China Conjugate Vaccines Market Share by Manufacturers (2015 and 2016)
Table China Conjugate Vaccines Sales by Type (2015 and 2016)
Table China Conjugate Vaccines Market Share by Type (2015 and 2016)
Table China Conjugate Vaccines Sales by Applications (2015 and 2016)
Table China Conjugate Vaccines Market Share by Applications (2015 and 2016)
Figure Japan Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure Japan Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Conjugate Vaccines Sales Price Trend (2011-2021)
Table Japan Conjugate Vaccines Sales by Manufacturers (2015 and 2016)
Table Japan Conjugate Vaccines Market Share by Manufacturers (2015 and 2016)
Table Japan Conjugate Vaccines Sales by Type (2015 and 2016)
Table Japan Conjugate Vaccines Market Share by Type (2015 and 2016)
Table Japan Conjugate Vaccines Sales by Applications (2015 and 2016)
Table Japan Conjugate Vaccines Market Share by Applications (2015 and 2016)
Figure India Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure India Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure India Conjugate Vaccines Sales Price Trend (2011-2021)
Table India Conjugate Vaccines Sales by Manufacturers (2015 and 2016)
Table India Conjugate Vaccines Market Share by Manufacturers (2015 and 2016)
Table India Conjugate Vaccines Sales by Type (2015 and 2016)
Table India Conjugate Vaccines Market Share by Type (2015 and 2016)
Table India Conjugate Vaccines Sales by Applications (2015 and 2016)
Table India Conjugate Vaccines Market Share by Applications (2015 and 2016)
Figure Southeast Asia Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure Southeast Asia Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Conjugate Vaccines Sales Price Trend (2011-2021)
Table Southeast Asia Conjugate Vaccines Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Conjugate Vaccines Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Conjugate Vaccines Sales by Type (2015 and 2016)
Table Southeast Asia Conjugate Vaccines Market Share by Type (2015 and 2016)
Table Southeast Asia Conjugate Vaccines Sales by Applications (2015 and 2016)
Table Southeast Asia Conjugate Vaccines Market Share by Applications (2015 and 2016)
Table Astellas Pharma Inc Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)